We are live on ! Find out more
RARX

Ra Pharmaceuticals, Inc. Common Stock
RARX

Delisted

RARX was delisted on the 1st of April, 2020.

Back to rankings

1 hedge funds and large institutions have $32K invested in Ra Pharmaceuticals, Inc. Common Stock in 2020 Q2 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 142 closing their positions.

New
Increased
Maintained
Reduced
Closed

99% less funds holding

Funds holding: 144 → 1 (-143)

100% less funds holding in top 10

Funds holding in top 10: 11 → 0 (-11)

100% less capital invested

Capital invested by funds: $2.47B → $32K (-$2.47B)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 142

Holders
1
Holders Change
-143
Holders Change %
-99.31%
% of All Funds
0.02%
Holding in Top 10
–
Holding in Top 10 Change
-11
Holding in Top 10 Change %
-100%
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
142
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
NMC
NEA Management Company
Maryland
-$295M
2
RCM
RA Capital Management
Massachusetts
-$233M
3
BlackRock
BlackRock
New York
-$213M
4
BBA
Baker Bros. Advisors
New York
-$101M
5
AAM
Alpine Associates Management
Florida
-$96.3M
Name Holding Trade Value Shares
Change 		Change in
Stake
Alyeska Investment Group
26
Alyeska Investment Group
Illinois
– -$22.3M -463,613 Closed
Allianz Asset Management
27
Allianz Asset Management
Germany
– -$22.3M -463,556 Closed
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
28
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Ontario, Canada
– -$21.4M -445,817 Closed
Northern Trust
29
Northern Trust
Illinois
– -$19.8M -412,861 Closed
GCIA
30
Gabelli & Co Investment Advisers
New York
– -$16.7M -347,727 Closed
Dimensional Fund Advisors
31
Dimensional Fund Advisors
Texas
– -$16.5M -343,215 Closed
Balyasny Asset Management
32
Balyasny Asset Management
Illinois
– -$15.7M -327,045 Closed
Morgan Stanley
33
Morgan Stanley
New York
– -$15.3M -319,579 Closed
AllianceBernstein
34
AllianceBernstein
Tennessee
– -$14.9M -310,218 Closed
Renaissance Technologies
35
Renaissance Technologies
New York
– -$14.4M -300,745 Closed
MAM
36
Melqart Asset Management
United Kingdom
– -$13.6M -283,000 Closed
IA
37
IndexIQ Advisors
New York
– -$13.2M -274,367 Closed
State of Wisconsin Investment Board
38
State of Wisconsin Investment Board
Wisconsin
– -$12.5M -259,994 Closed
Marshall Wace
39
Marshall Wace
United Kingdom
– -$12M -249,715 Closed
AC
40
Athanor Capital
New York
– -$10.8M -224,786 Closed
Charles Schwab
41
Charles Schwab
California
– -$10.4M -216,524 Closed
Norges Bank
42
Norges Bank
Norway
– -$9.6M -200,000 Closed
SAM
43
Sandell Asset Management
New York
– -$9.6M -200,000 Closed
Wellington Management Group
44
Wellington Management Group
Massachusetts
– -$8.75M -182,245 Closed
N
45
Nuveen
North Carolina
– -$6.96M -144,888 Closed
HA
46
Havens Advisors
New York
– -$6.88M -143,266 Closed
Bank of New York Mellon
47
Bank of New York Mellon
New York
– -$6.62M -137,886 Closed
Calamos Advisors
48
Calamos Advisors
Illinois
– -$5.89M -122,600 Closed
KC
49
Kellner Capital
New York
– -$5.77M -120,100 Closed
TS
50
Twin Securities
New York
– -$5.36M -111,614 Closed
1
2
3 4 5

RARX Hedge Fund Activity: Q2 2020 in Review

1 of the 4,877 institutional investors tracked by Wall St. Rank reported a position in Ra Pharmaceuticals, Inc. Common Stock (RARX) for Q2 2020, worth a combined $32K — down 100% from $2.47B a quarter earlier.

Sellers outnumbered buyers: 142 funds closed out of RARX and 0 opened new positions — a net loss of 142 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was NEA Management Company, exiting entirely with an estimated $295M sold.

  • 1 institutional investor held Ra Pharmaceuticals, Inc. Common Stock (RARX) as of Q2 2020, down from 144 in Q1 2020.
  • Funds reported $32K of Ra Pharmaceuticals, Inc. Common Stock stock for Q2 2020, down 100% quarter-over-quarter.
  • 0 funds opened new Ra Pharmaceuticals, Inc. Common Stock positions in Q2 2020 and 142 closed out, a net change of -142 holders.
  • The largest Ra Pharmaceuticals, Inc. Common Stock seller in Q2 2020 was NEA Management Company, an estimated $295M sold.

Based on aggregated 13F filings for Q2 2020.